Cargando…
Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
The failure of cytotoxic chemotherapy in breast cancers has been closely associated with the presence of drug resistant cancer stem cells (CSCs). Thus, screening for small molecules that selectively inhibit growth of CSCs may offer great promise for cancer control, particularly in combination with c...
Autores principales: | Jia, Deyong, Tan, Yuan, Liu, Huijuan, Ooi, Sarah, Li, Li, Wright, Kathryn, Bennett, Steffany, Addison, Christina L., Wang, Lisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808032/ https://www.ncbi.nlm.nih.gov/pubmed/26506421 |
Ejemplares similares
-
Cardamonin reduces chemotherapy resistance of colon cancer cells via the TSP50/NF-κB pathway in vitro
por: Lu, Sen, et al.
Publicado: (2018) -
An overview of the potential anticancer properties of cardamonin
por: Ramchandani, Shanaya, et al.
Publicado: (2020) -
Inhibitory Effect of Tangeretin and Cardamonin on Human Intestinal SGLT1 Activity In Vitro and Blood Glucose Levels in Mice In Vivo
por: Satsu, Hideo, et al.
Publicado: (2021) -
RANKL Signaling and Osteoclastogenesis Is Negatively Regulated by Cardamonin
por: Sung, Bokyung, et al.
Publicado: (2013) -
Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer
por: James, Shirley, et al.
Publicado: (2021)